ARKG vs ARKK
ARK Genomic Revolution ETF vs ARK Innovation ETF
ARKG$47.17
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: 0.75%Yield: 0.00%
ARKK$79.58
ARK Innovation ETF
Active disruptive-innovation strategy.
Expense: 0.75%Yield: 0.00%
Side-by-side metrics
| Metric | ARKG | ARKK |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.75% |
Dividend yield Trailing 12-month yield. | 0.00% | 0.00% |
AUM Assets under management — bigger funds are typically more liquid. | $2.21B | $6.12B |
YTD return | 66.55% | 2.68% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.11 | 2.45 |
P/E ratio | — | 51.36 |
Last price | $47.17 | $79.58 |
Inception | — | — |
Issuer | ARK | ARK |
ARKG top holdings
Top holdings · ARKG
| TWST | Twist Bioscience Corp | 8.75% |
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 8.73% |
| TEM | Tempus AI Inc Class A common stock | 8.36% |
| ABSI | Absci Corp | 5.56% |
| CRSP | CRISPR Therapeutics AG | 5.22% |
| GH | Guardant Health Inc | 4.88% |
| NTRA | Natera Inc | 4.71% |
| ILMN | Illumina Inc | 4.69% |
| LLY | Eli Lilly and Co | 3.92% |
| BEAM | Beam Therapeutics Inc | 3.69% |
Sector breakdown · ARKG
Healthcare100.0%
ARKK top holdings
Top holdings · ARKK
| TSLA | Tesla Inc | 10.65% |
| SPCX | Space Exploration Technologies Corp Class A | 6.13% |
| TEM | Tempus AI Inc Class A common stock | 5.61% |
| CRCL | Circle Internet Group Inc Ordinary Shares - Class A | 4.68% |
| CRSP | CRISPR Therapeutics AG | 4.44% |
| COIN | Coinbase Global Inc Ordinary Shares - Class A | 3.95% |
| TWST | Twist Bioscience Corp | 3.56% |
| SHOP | Shopify Inc Registered Shs -A- Subord Vtg | 3.11% |
| NVDA | NVIDIA Corp | 2.93% |
Sector breakdown · ARKK
Consumer Cyclical13.8%
Technology25.3%
Communication Services3.1%
Financial Services14.8%
Industrials12.2%
Healthcare30.8%
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $2.2B in assets under management, an expense ratio of 0.75%. Its largest holding is Twist Bioscience Corp (TWST), which represents 8.7% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About ARKK
ARKK (ARK Innovation ETF) is Active disruptive-innovation strategy. Managed by ARK, the fund carries $6.1B in assets under management, an expense ratio of 0.75%. Its largest holding is Tesla Inc (TSLA), which represents 10.7% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 13.8%.